Beryl Drugs Ltd

NSE: BERLDRG · BSE: 524606 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹25.55
Market cap: ₹12.96 Cr
Revenue (annual): ₹18.82 Cr
Net profit (annual): ₹0.42 Cr
P/E (TTM): 20.8×Sector 47.3×
Promoter holding: 27.82%+0.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Outcome 4 Board Meeting Date 4 Annual General Meeting 4 Promoter Buying 3 Other Announcement 3 Financial Results 3 Debt & Borrowing 1 Capacity Expansion 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

21 Jul 2026 13:05 IST BSE

Adverse Business Impact

Beryl Drugs Adverse Business Impact

Beryl Drugs Ltd reported the temporary unavailability of its corporate website due to technical issues. The company stated there is no impact on business operations.

Read the filing ↗